Copyright
©The Author(s) 2020.
World J Gastrointest Endosc. Nov 16, 2020; 12(11): 408-450
Published online Nov 16, 2020. doi: 10.4253/wjge.v12.i11.408
Published online Nov 16, 2020. doi: 10.4253/wjge.v12.i11.408
Ref. | Year | Country | Study design | n | Polyp morphology | Procedure | Medication | Relative risk |
Horiuchi et al[133] | 2014 | Japan | Prospective | 35 | Size: ≤ 10 mm | CSP | Warfarin (continued) | No incidences of PPB |
Makino et al[110] | 2018 | Japan | Prospective | 69 | Size: ≤ 10 mm | CSP | Warfarin (continued) | No incidences of PPB. Incidence of immediate/intraprocedural bleeding 5.7% |
Arimoto et al[111] | 2019 | Japan | Retrospective | 501 | Size: ≤ 10 mm | CSP | Warfarin (continued) | No incidences of PPB. Incidence of immediate/intraprocedural bleeding 9.8% |
- Citation: Chan A, Philpott H, Lim AH, Au M, Tee D, Harding D, Chinnaratha MA, George B, Singh R. Anticoagulation and antiplatelet management in gastrointestinal endoscopy: A review of current evidence. World J Gastrointest Endosc 2020; 12(11): 408-450
- URL: https://www.wjgnet.com/1948-5190/full/v12/i11/408.htm
- DOI: https://dx.doi.org/10.4253/wjge.v12.i11.408